Please Wait

Applying Filters...

Itrop
JDMF
Table View

Antibiotic market to reach US$ 74.07 billion by 2033; FDA approves GSK’s Blujepa for uncomplicated UTIs

Data Compilation
#PharmaFlow

Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

Stock Recap
#PipelineProspector

Itrop

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

35 API Suppliers, 9 USDMF, 8 CEP/COS, 1 JDMF, 5 EU WC, 9 KDMF, 14 NDC API, 20 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

36 Drugs in Development

36 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

248 FDF Dossiers, 45 FDA Orange Book, 140 Europe, 17 Canada, 4 Australia, 24 South Africa, 18 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SPRAY, METERED;NASAL - 0.021MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SPRAY, METERED;NASAL - 0.042MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;INHALATION - EQ 0.083% BASE;0.017% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 Kirsch Pharma, 5 Actylis, 1 Finar

EXCIPIENTS BY APPLICATIONS

6 Parenteral, 2 Solubilizers, 1 Thickeners and Stabilizers

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 16 News #PharmaBuzz

GLOBAL SALES INFORMATION

19 US Medicaid Prescriptions, 49 Regulatory FDF Prices, 1 Annual Reports

MARKET PLACE

11 APIs, 6 FDF Dossiers, 1 EXCIPIENTS

PATENTS & EXCLUSIVITIES

5 US Patents, 2 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 11 Others

$ Xls download

Filters

Log in to download the data

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	MF Registration No.	Classification	Initial Date of Reg.	Latest Date of Reg.	Registrant's Address
29/11/2025	Boehringer Ingelheim GmbH	Germany	Boehringer Ingelheim Pharma GmbH & Co. K.G.	220MF10081	Ipratropium bromide hydrate	2008-03-14	2023-11-08	Binger Strasse 173,55216 Ingelheim am Rhein

Contact us
to update this info

Itrop

Itrop

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

35 API Suppliers

9 USDMF

8 CEP/COS

1 JDMF

5 EU WC

9 KDMF

14 NDC API

20 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

36 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

248 FDF Dossiers

45 FDA Orange Book

140 Europe

17 Canada

4 Australia

24 South Africa

18 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SPRAY, METERED;NASAL - 0.021MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SPRAY, METERED;NASAL - 0.042MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SOLUTION;INHALATION - EQ 0.083% BASE;0.017% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 Kirsch Pharma

5 Actylis

1 Finar

EXCIPIENTS BY APPLICATIONS

6 Parenteral

2 Solubilizers

1 Thickeners and Stabilizers

DIGITAL CONTENT

1 Data Compilation #PharmaFlow

16 News #PharmaBuzz

GLOBAL SALES INFORMATION

19 US Medicaid Prescriptions

49 Regulatory FDF Prices

1 Annual Reports

MARKET PLACE

11 APIs

6 FDF Dossiers

1 EXCIPIENTS

PATENTS & EXCLUSIVITIES

5 US Patents

2 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM

11 Others

Filters

SPRAY, METERED;NASAL - 0.021MG/SPRAY Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SPRAY, METERED;NASAL - 0.042MG/SPRAY Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SOLUTION;INHALATION - EQ 0.083% BASE;0.017% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons